Clinical characteristics of the respiratory and cardiovascular systems in patients with combination of chronic obstructive pulmonary disease and heart failure
DOI:
https://doi.org/10.14739/2310-1210.2017.3.100572Keywords:
heart failure, chronic obstructive pulmonary disease, comorbidityAbstract
The aim of our work was to assess the respiratory and cardiovascular systems of patients with a combination of chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF).
Materials and methods. The study included 177 patients who had been diagnosed COPD by criteria GOLD. CHF was diagnosed in 77 (43.5 %) cases – 29 (16.4 %) with reduced systolic function and 48 (27.1 %) with preserved systolic function. We analyzed some important parameters characterizing respiratory and cardiovascular systems. We tried to identify statistically significant difference of parameters between patients with COPD and those with COPD and CHF. Moreover, patients with CHF were evaluated as a whole, and separately with reduced and with preserved systolic function.
Results. Thus, we observed significant deterioration in general clinical, laboratory, spirometric and echocardiographic parameters depending on the presence and severity of CHF in patients with COPD. In particular, the presence of CHF, especially with impaired systolic function significantly impair indicators such as incidence of cardiac arrhythmias and signs of ischemia on the ECG, NT-proBNP levels, prevalence of concentric, eccentric hypertrophy and concentric LV remodeling and diastolic dysfunction type "relaxation disorder", and incidence of a-wave absence during assessment of motion of the rear pulmonary artery valve wall. Listed changes as well as some of the tendencies that have not reached a certain level of significance, indicate that patients with COPD and concomitant CHF, especially with impaired systolic function, worsens general clinical parameters (breath rate, systolic blood pressure, heart rate, frequency arrhythmias and myocardial ischemia on ECG); laboratory levels of hemoglobin, hematocrit, cholesterol, glomerular filtration rate; spirometric indicators of bronchial obstruction (FEV1, FVC, instant volume expiratory flow rates); echocardiographic indicators suggest the deterioration of the heart geometry (increasing of myocardial mass index, indexes of LV end-systolic and end-diastolic volumes, increased frequency of all variants of LV pathological remodeling detection, RV wall thickness, the ratio of RV/LV) diastolic function impairment (increased frequency of all types diastolic dysfunction detection); development of pulmonary hypertension (increasing of the maximum flow velocity, pressure gradient, and the systolic pressure in the pulmonary artery, the frequency of detection of the absence of a-wave).
Conclusions. The presence of heart failure in patients with COPD worsens important clinical, laboratory and instrumental parameters of the cardiovascular and respiratory systems.
References
Gavrisyuk, V. K., Yachnik, A. Y., & Merenkova, E. A. (2014) Khronicheskoe legochnoe serdce v svete polozhenij mezhdunarodnykh rukovodstv NICE-COPD y GOLD [Chronic pulmonary heart in the light of international guidelines and NICE-COPD GOLD]. Ukrainskyi pulmonolohichnyi zhurnal, 2, 17–19. [in Russian].
Voronkov, L. H., Amosova, K. M., Bahrii, A. E., Dziak, H. V., Diadyk, O. I., Zharinov, et al. (2012) Rekomendatsii z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti (2012) [Recommendations for the diagnosis and treatment of chronic heart failure (2012)]. Sertseva nedostatnist: ukr nauk-prakt zhurn dlia likariv z problem sertsevoi nedostatnosti, 3, 60–96. [in Ukrainian].
Ponikowski, P. Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J., 37, 2129–2200.
Islam, M. A., Bari, M. S., Islam, M. N., Bari, M. A., Siddique, S. R., Islam, M. Z., et al. (2016) B-type Natriuretic Peptide Assay in Differentiating Congestive Heart Failure from Lung Disease in Patients Presenting with Dyspnea. Mymensingh Med. J., 25(3), 470–476.
Müllerova, H., Agusti, A., Erqou, S., & Mapel, D. W. (2013) Cardiovascular comorbidity in COPD: Systematic literature review. Chest J., 144(4), 1163–1178. doi: 10.1378/chest.12-2847.
Minasian, A. G., van den Elshout, F. J., Dekhuijzen, P. N., Vos, P. J., Willems, F. F., van den Bergh, P. J., & Heijdra, Y. F. (2013) COPD in chronic heart failure: Less common than previously thought? Heart & Lung, 42(5), 365–371. doi: 10.1016/j.hrtlng.2013.07.002.
Valk, M. J., Broekhuizen, B. D., Mosterd, A., Zuithoff, N. P., Hoes, A. W., & Rutten, F. H. (2015) COPD in patients with stable heart failure in the primary care setting. Int. J. Chron. Obstruct. Pulmon. Dis., 10, 1219–1224. doi: 10.2147/COPD.S77085.
Griffo, R., Spanevello, A., Temporelli, P. L., Faggiano, P., Carone, M., Magni, G., et al. (2017) SUSPIRIUM Investigators. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey. Eur. J. Prev. Cardiol., 2047487316687425.
Smith, B. M., Prince, M. R., Hoffman, E. A., Bluemke, D. A., Liu, C. Y., Rabinowitz, D., et al. (2013) Impaired Left Ventricular Filling In COPD And Emphysema: Is It The Heart Or The Lungs?: The Multi-Ethnic Study Of Atherosclerosis COPD Study. Chest J., 144(4), 1143–1151. doi: 10.1378/chest.13-0183.
Anderson, W. J., Lipworth, B. J., Rekhraj, S., Struthers, A. D., & George, J. (2013) Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room? Chest, 143(1), 91–97. doi: 10.1378/chest.12-0775.
Rahaghi, F. N., van Beek, E. J., & Washko, G. R. (2014) Cardiopulmonary coupling in chronic obstructive pulmonary disease: the role of imaging. J. Thorac. Imaging., 29(2), 80–91. doi: 10.1097/RTI.0000000000000076.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
